PTEN (phosphatase and tensin homolog) mutation or loss is present in up to 8.5-40% of CM, 7-28% of AM, and 1-25% of MM (5, 20, 22–24). This evidence concerns the gene PTEN and acute myeloblastic leukemia with maturation.